Digital Assets Report

Newsletter

Like this article?

Sign up to our free newsletter

Celoxica launches CME/ICE and Liffe/Eurex futures trading platforms

Related Topics

Celoxica, a provider of ultra low latency market data and order entry solutions for high frequency traders, has launched its next generation hardware-accelerated, futures trading platform for firms executing low latency trading strategies on futures exchanges.



Continued volatility and escalating market volumes in the global futures markets has led to trading firms increasingly seeking to capitalise on short-term disparities between pricing on both the US and European futures markets.

Celoxica’s futures trading platform provides a fully optimised, ultra-low latency market data and trade execution platform, with single digit latencies from wire to wire irrespective of market conditions.

Based on FPGA technology the trading platform can accelerate market data into trading algorithms and rapidly execute orders, ensuring fills are met across multiple trading strategies including fixed income, commodities and foreign exchange. Celoxica’s FPGA cards are compatible with standard PCIe slots allowing for easy installation as well as increased efficiency achieved through reducing server number and co-location costs. 

“For Futures trading, processing speed, determinism and throughput continue to play a crucial role in the success of principle trading firms and hedge funds trading on the global futures markets” says Jean Marc Bouhelier, Celoxica’s chairman and chief executive. “Celoxica’s ability to offer next generation systems to address these key technology and business requirements, whilst ensuring costs are minimised, means our clients and partners can increase focus on their trading strategies for CME, ICE, CFE, Liffe US, Liffe and Eurex, knowing they are using the most efficient trading platform for market data and order execution available on the market today.”

The Hedgeweek Awards 2013 for the best hedge fund performers and service providers will be held in London towards the end of Q1 2013. Please click here to nominate your product/firm.

Like this article? Sign up to our free newsletter

Most Popular

Further Reading

Featured